Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Harley

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Otolaryngologic Clinics of North America|June 1, 1996
Eustachian tube dysfunctionE M Monsell, R E Harley
JPMA. the Journal of the Pakistan Medical Association|January 1, 1994
An assessment of corn oil as a vehicle for cyclosporin A (CsA) at varied injection sites in preventing rejection of rat laryngeal allograftsJ Wu, H Jalisi, C E Yang, et al.
Diabetes, Obesity & Metabolism|March 3, 2011
Dose response of subcutaneous GLP-1 infusion in patients with type 2 diabetesS S Torekov, M S Kipnes, R E Harley, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|November 8, 2003
Recombinant glucagon-like peptide-1 (7-36 amide) lowers fasting serum glucose in a broad spectrum of patients with type 2 diabetesM R Ehlers, L J Klaff, D A D'Alessio, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Otolaryngologic Clinics of North America|June 1, 1996
Eustachian tube dysfunctionE M Monsell, R E Harley
JPMA. the Journal of the Pakistan Medical Association|January 1, 1994
An assessment of corn oil as a vehicle for cyclosporin A (CsA) at varied injection sites in preventing rejection of rat laryngeal allograftsJ Wu, H Jalisi, C E Yang, et al.
Diabetes, Obesity & Metabolism|March 3, 2011
Dose response of subcutaneous GLP-1 infusion in patients with type 2 diabetesS S Torekov, M S Kipnes, R E Harley, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|November 8, 2003
Recombinant glucagon-like peptide-1 (7-36 amide) lowers fasting serum glucose in a broad spectrum of patients with type 2 diabetesM R Ehlers, L J Klaff, D A D'Alessio, et al.
Pageof 1